UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | W | Y | Z
Number of items: 322.

A

Ajzensztejn, D; Hegde, V; Lee, SM; (2006) Tumour lysis syndrome following treatment with standard second-line docetaxel for non-small cell lung cancer. Journal of Clinical Oncology , 24 (15) pp. 2389-2391.

Al-Mahdawi, S; Pinto, RM; Varshney, D; Lawrence, L; Lowrie, MB; Hughes, S; Webster, Z; ... Pook, MA; + view all (2006) GAA repeat expansion mutation mouse models of Friedreich's ataxia exhibit oxidative stress leading to progressive neuronal cardiac pathology. Genomics , 88 (5) pp. 580-590.

Alonzi, R; Hoskin, P; (2006) Functional imaging in clinical oncology: Magnetic resonance imaging- and computerised tomography-based techniques. CLINICAL ONCOLOGY , 18 (7) pp. 555-570.

Amary, MFC; Lam, L; Bernardi, FDC; Michelagnoli, M; Berisha, F; Diss, T; Flanagan, AM; (2006) SYT-SSX fusion transcript can be detected in a very high proportion of formalin-fixed paraffin-embedded synovial sarcomas using conventional, real-time RT-PCR and FISH. In: (Proceedings) 190th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. (pp. p. 26). WILEY-BLACKWELL

Arkenau, HT; (2006) 42nd annual meeting of the American society of clinical oncology, Atlanta, USA, 2006: Adjuvant treatment for colon and rectal cancer. Advances in Gastrointestinal Cancers , 4 (2) pp. 21-22.

Arnould, S; Spanswick, VJ; Macpherson, JS; Hartley, JA; Thurston, DE; Jodrell, DI; Guichard, SM; (2006) Time-dependent cytotoxicity induced by SJG-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling. Mol Cancer Ther , 5 (6) pp. 1602-1609. 10.1158/1535-7163.MCT-06-0018.

Austin, S; Cohen, H; (2006) Antiphospholipid syndrome. Medicine , 34 (11) pp. 472-475. 10.1053/j.mpmed.2006.08.012.

Austin, SK; Lawrie, AS; Starke, RD; Scully, M; Machin, SJ; Cohen, H; Mackie, IJ; (2006) ADAMTS13 antibodies in patients with antiphospholipid antibodies. In: (pp. p. 94).

B

Baker, RJ; Hughes, DA; Ioannidis, A; Milligan, A; Blincoe, M; Mehta, AB; (2006) Measurement of alpha-galactosidase A activity in tears. Presented at: UNSPECIFIED.

Baum, M; Hackshaw, A; Houghton, J; Rutqvist, L; Fornander, T; Nordenskjold, B; Nicolucci, A; (2006) Adjuvant goserelin in premenopausal patients with early breast cancer: results from the ‘Zoladex’ in premenopausal patients (ZIPP) trial. European Journal of Cancer , 42 pp. 895-904.

Beck, M; Cox, TM; Gal, A; Mehta, AB; (2006) Lysosomal Diseases, Natural Course, Pathophysiology and Therapy. [Book]. (Vol.96, su). Blackwell

Beck, S; (2006) Epigenetics - The missing link between genetics, disease and the environment. TOXICOL LETT , 164 S18 - S19. 10.1016/j.toxlet.2006.06.042.

Begent, R; (2006) Developing Integrated Informatics Platform for Cancer Research. In: Nagl, S, (ed.) Cancer Bioinformatics: From Therapy Design to Treatment. (pp. 45-55). John Wiley & Sons: Chichester.

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Cossarizza, A; Melino, G; Heery, D; (2006) Cytoplasmic Function of Mutant Promyelocytic Leukemia (PML) and PML-Retinoic Acid Receptor-alpha. J BIOL CHEM , 281 (20) 14465 - 14473. 10.1074/jbc.M600457200. Gold open access

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Cossarizza, A; Melino, G; Heery, D; (2006) Cytoplasmic function of mutant PML and PML-RARalpha. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 27 - 27). BLACKWELL PUBLISHING

Benjamin, R; Davidoff, AM; Singh, N; Mcintosh, J; Khwaja, A; Streck, C; Ng, C; ... Nathwani, AC; + view all (2006) Therapeutic efficacy of interferon-beta in a xenograft model of acute myeloid leukaemia. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 62 - 63). BLACKWELL PUBLISHING

Beresford, M; Sanghera, B; Wong, WL; Makris, A; (2006) Imaging of primary breast cancer with F-18-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour. SPRINGER, 233 SPRING STREET, NEW YORK, NY 10013 USA

Beresford, MJ; Burcombe, R; Ah-See, ML; Stott, D; Makris, A; (2006) Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer. CLINICAL ONCOLOGY , 18 (6) pp. 453-458.

Beresford, MJ; Chin, Y; Burcombe, Y; Ah-See, M; Makris, A; (2006) Clinical response assessment after 2 cycles of neoadjuvant chemotherapy for primary breast cancer fails to predict for final clinical response, but does predict for pathological complete response. In: (pp. 44S-44S).

Beresford, MJ; Harris, AL; Ah-See, M; Daley, F; Padhani, AR; Makris, A; (2006) The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer. BRITISH JOURNAL OF CANCER , 95 (12) pp. 1683-1688.

Beresford, MJ; Padhani, AP; Taylor, NJ; Ah-See, M-L; Stirling, JJ; Makris, A; d'Arcy, JA; (2006) Inter- and intraobserver variability in the evaluation of dynamic breast cancer MRI. Journal of Magnetic Resonance Imaging , 24 (6) pp. 1316-1325. 10.1002/jmri.20768.

Beresford, MJ; Wilson, GD; Makris, A; (2006) Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Research , 8 (6)

Beyan, H; Rakyana, V; Hawa, MI; Browne, P; Beck, S; Leslie, DRD; (2006) Epigenetic methylation of type 1 diabetes susceptibility genes. In: DIABETES. (pp. A545 - A545). AMER DIABETES ASSOC

Bielack, S; Sydes, M; Butterfass-Bahloul, T; Anninga, J; Benninger-Doring, G; Calaminus, G; Dhooge, KC; ... Bernstein, M; + view all (2006) Successful multinational implementation of the European and American Osteosarcoma study EURAMOS-1 within the European Science Foundation's ECT-EUROCORES scheme. In:

Bishton, MJ; Lush, R; Russell, NH; Shaw, BE; Haynes, AP; (2006) Ifosphamide, etoposide and epirubicin (IVE) is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with lymphoma. In: BLOOD. (pp. 688A - 688A). AMER SOC HEMATOLOGY

Blay, J; Le Cesne, A; Whelan, J; Van Oosterom, A; Ray-Coquard, I; Judson, L; Hogendorn, P; ... Van Glabbeke, M; + view all (2006) Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of EORTC Soft Tissue and Bone Sarcoma Group. In: (pp. 9517-).

Blay, J; Le Cesne, A; Whelan, J; Van Oosterom, A; Ray-Coquard, I; Judson, L; Hogendorn, P; ... Van Glabbeke, M; + view all (2006) Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of EORTC Soft Tissue and Bone Sarcoma Group. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 524S - 524S). AMER SOC CLINICAL ONCOLOGY

Boshoff, C; (2006) The biology of cancer. NATURE , 444 (7119) 549 - 549. 10.1038/444549a.

Bourhis, J; Overgaard, J; Audry, H; Ang, KK; Saunders, M; Bernier, J; Horiot, JC; ... Pignon, JP; + view all (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. , 368 (9538) pp. 843-854. 10.1016/S0140-6736(06)69121-6.

Bower, M; Gazzard, B; Mandalia, S; Newsom-Davis, T; Thirlwell, C; Dhillon, T; (2006) A prognostic index for systemic AIDS-related non-hodgkin lymphoma treated in the era of highly active antiretroviral therapy (vol 143, pg 265, 2005). ANN INTERN MED , 144 (8) 620 - 620.

Bridgewater, JA; Floore, A; Warmoes, MO; Veer Van't, L; (2006) Can gene expression microarray (GEM) provide a diagnosis in cases of carcinoma of unknown primary? J Clin Oncol , 24 (18_suppl) 20117-.

Brissault, B; Kichler, A; Leborgne, C; Danos, O; Cheradame, H; Gau, J; Auvray, L; (2006) Synthesis, characterization, and gene transfer application of poly(ethylene glycol-b-ethylenimine) with high molar mass polyamine block. Biomacromolecules , 7 (10) pp. 2863-2870. 10.1021/bm060499a.

Buchmueller, K; Bailey, S; Matthews, D; Register, J; Bruce, CD; O'Hare, C; Hartley, J; ... Lee, M; + view all (2006) Molecular recognition of polyamides with DNA: A study on the strong binding of f-ImPyIm to its cognate DNA, ACGCGT. In: (pp. 678-).

Burckbuchler, V; Wintgens, V; Lecomte, S; Percot, A; Leborgne, C; Danos, O; Kichler, A; (2006) DNA compaction into new DNA vectors based on cyclodextrin polymer: surface enhanced Raman spectroscopy characterization. Biopolymers , 81 (5) pp. 360-370. 10.1002/bip.20428.

Burcombe, R; Wilson, GW; Dowsett, M; Khan, I; Richman, PI; Daley, F; Detre, S; (2006) Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Research , 8 (3) R31-. 10.1186/bcr1508.

Burton, C; Linch, D; Hoskin, P; Milligan, D; Dyer, MJS; Hancock, B; Mouncey, P; ... Cunningham, D; + view all (2006) A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. Br J Cancer , 94 (6) pp. 806-813. 10.1038/sj.bjc.6602975.

Butcher, LM; Kennedy, JK; Plomin, R; (2006) Generalist genes and cognitive neuroscience. Curr.Opin.Neurobiol. , 16 (2) pp. 145-151. 10.1016/j.conb.2006.03.004.

C

Cardigan, R; Lawrie, A; Mackie, I; Williamson, L; (2006) Effect of overnight 4 degrees C storage of whole blood on von Willebrand factor: reply. TRANSFUSION , 46 (6) 1059 - 1060.

Carmo, M; Faria, TQ; Falk, H; Coroadinha, AS; Teixeira, M; Merten, O-W; Gény-Fiamma, C; ... Cruz, PE; + view all (2006) Relationship between retroviral vector membrane and vector stability. J Gen Virol , 87 (Pt 5) pp. 1349-1356. 10.1099/vir.0.81302-0.

Carnell, DM; Smith, RE; Daley, FM; Saunders, MI; Bentzen, SM; Hoskin, PJ; (2006) An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: Implications for radioresistance. International Journal of Radiation Oncology Biology Physics , 65 (1) pp. 91-99.

Caroline, R; (2006) I was saved from death by cells harvested from my bones. The Daily Mail

Carrasco, DR; Fenton, T; Sukhdeo, K; Protopopova, M; Enos, M; You, MJ; Di Vizio, D; ... Depinho, RA; + view all (2006) The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer Cell , 9 (5) pp. 379-390. 10.1016/j.ccr.2006.03.028.

Casado, E; Tabernero, J; Melichar, B; Bridgewater, J; Bennouna, J; Delord, J; Sopala, M; ... Johri, A; + view all (2006) Patupilone in chemotherapy-pretreated patients with advanced colorectal cancer (CRC) receiving nutritional support and intensive diarrhea management: A phase I multicenter trial. J Clin Oncol , 24 (18_suppl) 3593-.

Caswell, R; Warner, TT; Mehta, A; Ginsberg, L; (2006) POEMS syndrome. Practical Neurology , 6 pp. 14-26.

Cave, J; Davis, B; Lee, SM; Jones, A; (2006) A randomised controlled trial comparing symptom-based and tumour-based teaching for undergraduates medical students. In: (Proceedings) 2006 NCRI Cancer Conference, Birmingham.. (pp. 192-). Annals of Oncology

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance. Oncogene , 25 (56) pp. 7411-7420. 10.1038/sj.onc.1209727.

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol Cancer Ther , 5 (7) pp. 1669-1675. 10.1158/1535-7163.MCT-06-0033.

Chakraverty, R; Dimopoulou, M; Glanville, J; Thomson, K; Peggs, K; Milligan, D; Cook, G; ... Mackinnon, S; + view all (2006) De-Escalation of the Alemtuzumab Dose Prior to Nonmyeloablative HLA-Identical Sibling Transplantation: Crucial Role of Timing. In: (Proceedings) American Society of Haematology.

Chang, JC; Makris, A; Hilsenbeck, SJ; Hackett, JR; Jeong, J; Liu, M; Baker, J; ... Shak, S; + view all (2006) Gene expression profiles in formalin-fixed, paraffin-embedded (FFPE) core biopsies predict docetaxel chemosensitivity. In: (pp. 12S-12S).

Channel, 5N; (2006) Cancer drug battle. UNSPECIFIED

Chicken, DW; Clarke, B; Mosse, S; Falzon, M; Kocjan, G; Bown, S; Keshtgar, MRS; (2006) Rapid Intraoperative Diagnosis of Sentinel Node Metastases in Breast Cancer using Elastic Scattering Spectroscopy Scanning. In: (pp. p. 1026).

Chicken, DW; Clarke, BR; Johnson, KS; Falzon, M; Novelli, M; Bigio, IJ; Bown, SG; (2006) Elastic scattering spectroscopy – a rapid optical technique for detection of sentinel node metastases in breast cancer. In: (pp. 104-).

Chicken, DW; Kocjan, G; Falzon, M; Lee, AC; Douek, M; Sainsbury, R; Keshtgar, MRS; (2006) Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer. BRIT J SURG , 93 (5) 572 - 576. 10.1002/bjs.5289.

Chin, Y; Ravichandran, D; Makris, A; (2006) Exemestane after non-steroidal aromatase inhibitors for post-menopaual women with advanced breast cancer. In: (pp. 167-).

Chin, YS; Bullard, J; Bryant, L; Bownes, P; Ostler, P; Hoskin, PJ; (2006) High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer. CLINICAL ONCOLOGY , 18 (7) pp. 474-479.

Cholongitas, E; Quaglia, A; Dhillon, AP; Patch, D; Burroughs, AK; (2006) Length versus width in liver biopsies. J HEPATOL , 44 (4) 822 - 823. 10.1016/j.jhep.2005.12.023.

Cholongitas, E; Quaglia, A; Samonakis, D; Papatheodoridis, GV; Patch, D; Dhillon, AP; Burroughs, AK; (2006) Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progression. In: LIVER TRANSPLANTATION. (pp. C60 - C60). JOHN WILEY & SONS INC

Cholongitas, E; Quaglia, A; Samonakis, D; Papatheodoridis, GV; Senzolo, M; Triantos, C; Patch, D; ... Burroughs, AK; + view all (2006) Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progression. In: JOURNAL OF HEPATOLOGY. (pp. S58 - S59). ELSEVIER SCIENCE BV

Cholongitas, E; Samonakis, D; Manousou, P; Shusang, V; Dhillon, AP; Quaglia, A; Sharma, D; ... Burroughs, AK; + view all (2006) Randomised trial of tacrolimus monotherapy vs. tacrolimus/azathioprine/prednisolone after liver transplantation for HCV cirrhosis. LIVER TRANSPLANTATION , 12 (5) C61 - C61.

Chow, E; Hoskin, P; van der Linden, Y; Bottomley, A; Velikova, G; (2006) Quality of life and symptom end points in palliative bone metastases trials. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Chow, E; Hoskin, PJ; Wu, J; Roos, D; van der Linden, Y; Hartsell, W; Vieth, R; ... Pater, J; + view all (2006) A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Clark, DA; Leong, HN; Nacheva, EP; Tsao, EHF; Griffiths, PD; Ward, KN; (2006) Chromosomal integration of human herpesvirus 6. In: JOURNAL OF CLINICAL VIROLOGY. (pp. S104 - S104). ELSEVIER SCIENCE BV

Clark, DA; Tsao, EHF; Leong, HN; Ward, KN; Nacheva, EP; Griffiths, PD; (2006) Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells - Reply to Boutolleau et al. and Luppi et al. J INFECT DIS , 194 (7) 1021 - 1023.

Cleator, S; Makris, A; Powles, T; (2006) Response to letter "Analysis of breast cancer survival by clinical response to neoadjuvant chemoendocrine therapy" by Bogaerts et al. (Ann Oncol 2006; 17 : 352-353). UNSPECIFIED

Cohen, H; Austin, SK; Lawrie, AS; Starke, RD; Scully, M; Machin, S; Cohen, H; (2006) ADAMTS13 antibodies in patients with antiphospholipid antibodies. In:

Crespo, M; Villamor, N; Gine, E; Muntanola, A; Colomer, D; Marafioti, T; Jones, M; ... Bosch, F; + view all (2006) ZAP-70 expression in normal pro/pre B cells, mature B cells, and in B-cell acute lymphoblastic leukemia. CLINICAL CANCER RESEARCH , 12 (3) pp. 726-734. 10.1158/1078-0432.CCR-05-1531.

D

Dachs, GU; Steele, AJ; Coralli, C; Kanthou, C; Brooks, AC; Gunningham, SP; Currie, MJ; ... Tozer, GM; + view all (2006) Anti-vascular agent Combretastatin A-4-P modulates Hypoxia Inducible Factor-1 and gene expression. BMC Cancer , 6 , Article 280. 10.1186/1471-2407-6-280. Green open access
file

Dahl, KN; Scaffidi, P; Islam, MF; Yodh, AG; Wilson, KL; Misteli, T; (2006) Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proceedings of the National Academy of Sciences , 103 (27) pp. 10271-10276. 10.1073/pnas.0601058103.

Damelin, M; Ooi, SKT; Bestor, TH; (2006) Combing over heritable gene silencing. NAT STRUCT MOL BIOL , 13 (2) 100 - 101. 10.1038/nsmb0206-100.

Daniels, S; Statham, P; Globe, D; Seddon, B; Whelan, J; (2006) Piloting a novel method of administration – Moving inpatient treatments to ambulatory care. In:

Danos, O; Svinartchouk, F; (2006) Dialysis-assisted two-dimensional gel electrophoresis. Electrophoresis , 27 (17) pp. 3475-3479. 10.1002/elps.200500036.

Das-Gupta, EP; Byrne, JL; Gilyead, M; Shaw, BE; Russell, NH; (2006) Long-term results of pre-transplant in vivo alemtuzumab for unrelated donor transplantation in acute myeloid leukaemia. In: BONE MARROW TRANSPLANTATION. (pp. S116 - S116). NATURE PUBLISHING GROUP

De Santis, D; Witt, C; Gomez-Lozano, N; Vilches, C; Garcia, CA; Marsh, SGE; Williams, F; ... Christiansen, F; + view all (2006) A multi-laboratory evaluation of reference cells for KIR typing. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1233-1236). IHWG Press: Seattle.

Direkze, S.G.; (2006) Characterisation of transcriptional mediator subunit, MED17 and its regulation by cyclins. Doctoral thesis , University of London. Green open access
file

Donovan, E; Coles, C; Westbury, C; Yarnold, J; (2006) Breast. In: External Beam Therapy. Oxford University Press

Duarte, RF; Pamphilon, D; Cornish, J; Shaw, BE; Samson, D; Craddock, C; Marks, D; ... Goldman, JM; + view all (2006) Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005. BONE MARROW TRANSPL , 37 (10) 901 - 908. 10.1038/sj.bmt.1705365.

Dzwonek, A; Clapson, M; Withey, S; Bates, A; Novelli, V; (2006) Severe gynecomastia in an African boy with perinatally acquired human immunodeficiency virus infection receiving highly active antiretroviral therapy. The Pediatric Infectious Disease Journal , 25 (2) pp. 183-184.

E

El, EE; Dearling, J; Huhalov, A; Robson, P; Neri, D; van, DGA; Zardi, L; ... Pedley, RB; + view all (2006) Targeting the tumour vasculature: therapeutic efficacy of a 131I-labeled antibody against the ED-B domain of fibronectin. In: (Proceedings) NCRI Cancer Conference proceedings. (pp. 63-).

El, EE; Dearling, J; Huhalov, A; Robson, P; Neri, D; van, DGA; Zardi, L; ... Pedley, RB; + view all (2006) Targeting tumour vasculature in human colorectal xenografts using an antibody against the extra-domain B of fibronectin. BACR/BMS Tumour vasculature: New targets and Therapies. In: (pp. 18-).

Enver, T; Tsuzuki, S; Brown, J; Hong, D; Gupta, R; Ford, A; Egguchi, MI; ... Greaves, M; + view all (2006) Developmental impact of leukemic fusion genes on stem cell fate. Ann N Y Acad Sci. , 1044 pp. 16-23. 10.1196/annals.1349.003.

Etessami, N; Lam, L; Berisha, F; Flanagan, AM; Diss, TC; (2006) Improved detection of FUS-CHOP fusion transcript in myxoid liposarcoma using real-time RT-PCR. In: (Proceedings) 190th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. (pp. p. 25). WILEY-BLACKWELL

F

Field, D; Wilson, G; van der Gast, C; (2006) How do we compare hundreds of bacterial genomes? Curr Opin Microbiol , 9 (5) pp. 499-504.

Fitzmaurice, DA; Gardiner, C; Kitchen, S; Mackie, I; Murray, ET; Machin, SJ; (2006) Erratum: An evidence based review and guidelines for patient self-testing and management of oral anticoagulation (British Journal of Haematology (2005) 131 (156-165)). British Journal of Haematology , 132 (1) 118-. 10.1111/j.1365-2141.2005.05830.x.

Flanagan, J; Popendikyte, V; Pozdniakovaite, N; Sobolev, M; Assadzadeh, A; Schumacher, A; Zangeneh, M; ... Petronis, A; + view all (2006) Intra- and Inter- Individual Epigenetic Variation in Human Germ Cells. The American Journal of Human Genetics , 79 (1) pp. 67-84.

Flood, C; Cosgrove, T; Howell, I; Revell, P; (2006) Effects of electrolytes on adsorbed polymer layers: poly(ethylene oxide)-silica system. Langmuir , 23 (5) pp. 2408-2413. 10.1021/la062034b.

Forbes, S; Clements, J; Dawson, E; Bamford, S; Webb, T; Dogan, A; Flanagan, AM; ... Stratton, MR; + view all (2006) COSMIC 2005. British Journal of Cancer , 94 (2) pp. 310-322.

Ford, HER; Yap, YS; Miles, DW; Makris, A; Hall, M; Miller, L; Harries, M; ... Johnston, SRD; + view all (2006) A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer. Cancer Chemotherapy and Pharmacology , 58 (6) pp. 809-815.

Foroni, L; Mitchell, W; Rai, L; Gerrard, G; Patel, B; Goldstone, A; (2006) Molecular monitoring of minimal residual disease in adult ALL, the UKALL12 trial experience. In: (Proceedings) 46th Annual Scientific Meetign of the British-Society-for-Haematology. (pp. p. 52). BLACKWELL PUBLISHING

Fox, J; Patkar, V; Thomson, R; (2006) Decision support for health care: the PROforma evidence base. Inform Prim Care , 14 (1) pp. 49-54.

Fry, AM; Yamano, H; (2006) APC/C-mediated degradation in early mitosis: how to avoid spindle assembly checkpoint inhibition. Cell Cycle , 5 (14) pp. 1487-1491.

Fukuuchi, A; Nagamura, Y; Yaguchi, H; Ohkura, N; Obara, T; Tsukada, T; (2006) A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1. Jpn J Clin Oncol , 36 (11) pp. 739-744. 10.1093/jjco/hyl089.

G

Garcia, CA; Robinson, J; Guethlein, LA; Vilches, C; Parham, P; Madrigal, JA; Marsh, SGE; (2006) Human Killer-cell Immunoglobulin-like Receptor (KIR) polymorphism. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1208-1232). IHWG Press: Seattle.

Garcia, CA; Robinson, J; Shilling, HG; Guethlein, LA; Parham, P; Madrigal, JA; Marsh, SGE; (2006) KIR gene characterisation of HLA homozygous cell lines. In Immunobiology of the Human MHC. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1203-1207). IHWG Press: Seattle.

Gardiner, C; Cohen, H; Austin, SK; Machin, SJ; Mackie, IJ; (2006) Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C. J THROMB HAEMOST , 4 (12) 2724 - 2726.

Gardiner, C; Cohen, H; Austin, SK; Machin, SJ; Mackie, IJ; (2006) Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C. Journal of thrombosis and haemostasis : JTH , 4 pp. 2724-2726.

Gardiner, C; Cohen, H; Jenkins, A; Machin, SJ; Mackie, IJ; (2006) Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay. BLOOD COAGUL FIBRIN , 17 (6) 477 - 483.

Gardiner, C; Williams, K; Longair, I; Mackie, IJ; Machin, SJ; Cohen, H; (2006) A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. BRIT J HAEMATOL , 132 (5) 598 - 603. 10.1111/j.1365-2141.2005.05899.x.

Gerrard, G; Mitchell, W; Patel, B; Goldstone, A; Fielding, A; Foroni, L; (2006) Minimal residual disease monitoring of BCR-ABL(+) adult acute lymphoblastic leukaemia using quantitative real-time PCR: preliminary results from the UKALLXII trial. In: (Proceedings) 46th Annual Scientific Meetign of the British-Society-for-Haematology. (pp. pp. 53-54). BLACKWELL PUBLISHING

Gilardi, F; Viviani, B; Torri, A; Bartesaghi, S; Maschi, O; Caruso, D; Crestani, M; ... De Fabiani, E; + view all (2006) Differential expression and regulation of genes involved in cholesterol metabolism in brain cells. In: CHEMISTRY AND PHYSICS OF LIPIDS. (pp. 93 - 93). ELSEVIER IRELAND LTD

Glynne-Jones, R; Grainger, J; Harrison, M; Ostler, P; Makris, A; (2006) Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? BRITISH JOURNAL OF CANCER , 94 (3) pp. 363-371.

Gomez, K; McVey, JH; (2006) Tissue factor initiated blood coagulation. Front Biosci , 11 pp. 1349-1359.

Goodwin, S; Richfield, L; Milligan, A; Bruce, R; Blincoe, M; Hughes, D; Mehta, A; ... Elliott, P; + view all (2006) A pitfall in screening for Anderson-Fabry disease in patients with hypertrophic cardiomyopathy - a case report. Presented at: UNSPECIFIED.

Graham, J; Wagner, K; Plummer, R; Wiedenmann, B; Cassidy, J; Kowal, K; McCoy, C; (2006) Phase I dose-escalation study of novel oral multi-target tumor growth inhibitor (MTGI) ZK 304709 administered daily for 7 days of a 21-day cycle to patients with advanced solid tumors. J Clin Oncol , 24 (18_suppl) 2073-.

Green, AJ; Begent, RHJ; (2006) Generation of voxel phantoms to investigate the effect of statistical noise on image analysis programs. In: (pp. S319-).

Green, AJ; Begent, RHJ; (2006) Generation of voxel phantoms to investigate the effect of statistical noise on image analysis programs. EUR J NUCL MED MOL I , 33 S319 - S319.

Gregory, SG; Barlow, KF; McLay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; ... Prigmore, E; + view all (2006) The DNA sequence and biological annotation of human chromosome 1. Nature , 441 (7091) pp. 315-321. 10.1038/nature04727.

Gross, D-A; Chappert, P; Leboeuf, M; Monteilhet, V; Van Wittenberghe, L; Danos, O; Davoust, J; (2006) Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products. Blood , 108 (6) pp. 1841-1848. 10.1182/blood-2006-02-011981.

Gupta, N; Saleem, A; Kotz, B; Osman, S; Aboagye, EO; Phillips, R; Vernon, C; ... Price, PM; + view all (2006) Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients. CLINICAL CANCER RESEARCH , 12 (10) pp. 3115-3123.

Gutierrez-Rodriguez, ME; Sandoval-Ramirez, L; Diaz-Flores, M; Marsh, SGE; Valladares-Salgado, A; Madrigal, JA; Mejia-Arangure, JM; ... Cruz, M; + view all (2006) KIR gene in ethnic and Mestizo populations from Mexico. Human Immunology , 68 pp. 135-146.

H

Hackshaw, A; (2006) Smoke gets in your eyes – well only until mid-2007. Significance , 3 (2) pp. 63-65.

Hackshaw, AK; Paul, EA; Davenport, E; (2006) Evidence-based dentistry: an introduction. [Book]. (1st ed.). Blackwell Munksgaard: UK.

Hajioff, D; Hegemann, S; Conti, G; Beck, M; Sunder-Plassmann, G; Widmer, U; Mehta, A; (2006) 6 Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey. European Journal of Clinical Investigation , 36 (9) pp. 663-667.

Harland, SJ; Daugaard, G; Horwich, A; Mead, GM; Fossa, SD; Sokal, M; Morgenstern, D; ... National, CRITCCSG; + view all (2006) The familial influence on bilateral testicular germ cell cancer: Medical Research Council study TER2. In: (pp. 239S, 4590-).

Hayes, MJ; Kimata, Y; Wattam, SL; Lindon, C; Mao, G; Yamano, H; Fry, AM; (2006) Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C. Nat. Cell Biol. , 8 (6) pp. 607-614.

Hegemann, S; Hajioff, D; Conti, G; Beck, M; Sunder-Plassmann, G; Widmer, U; Mehta, A; (2006) Hearing loss in Fabry disease: data from the Fabry Outcome Survey. European Journal of Clinical Investigation , 36 (9) pp. 654-662.

Hernandez, D; Chandan, P; Janmohamed, A; Phillips, LR; Shephard, EA; (2006) Deletion of genes from the mouse genome using Cre/loxP technology. In: UNSPECIFIED (pp. 307-319).

Hernandez, D; I R, S; E, A; (2006) Characterization of targeted mouse embryonic stem cells. In: Phillips, IR and Shephard, EA, (eds.) Cytochrome P450 protocols. (pp. 321-327). Humana Press: Totowa, New Jersey.

Hing, KA; Revell, PA; Smith, N; Buckland, T; (2006) Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials , 27 (29) pp. 5014-5026. 10.1016/j.biomaterials.2006.05.039.

Ho, E; Vassileva, V; Lim-Soo, P; Allen, C; Piquette-Miller, M; (2006) Impact of localized, sustained delivery of paclitaxel on the in vitro and in vivo regulation of P-glycoprotein. In: (Proceedings) 107th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics. (pp. P11-P11). MOSBY, INC

Hollak, CEM; Hughes, D; Schwierin, B; Bembi, B; (2006) IS3: An approach to safety monitoring in daily practice. J INHERIT METAB DIS , 29 42 - 42.

Holmes, AM; Baker, RJ; Reed, MC; Richfield, L; Milligan, A; Bruce, R; Blincoe, M; ... Hughes, DA; + view all (2006) Adhesion of cultured macrophages predicts clinical phenotype in Anderson-Fabry disease. Presented at: UNSPECIFIED.

Howard, J; Brazma, D; Vaughan, BR; Nacheva, EP; (2006) Polysomy 8 in CML. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 65 - 65). BLACKWELL PUBLISHING

Hsu, KC; Bignon, JD; Carrington, M; Chida, S; Christiansen, F; De Santis, D; Eljaafari, A; ... Dupont, B; + view all (2006) 13th IHWS NK/KIR Joint Report. Killer immunoglobulin-like receptor genotypes, haplotypes and haplotype segregation patterns evaluated in the workshop KIR reference DNA panel. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1169-1199). IHWG Press: Seattle.

Hughes, DA; Duke, V; Baker, RJ; Wright, F; Foronii, L; Mehta, AB; (2006) High prevalence of B-cell clonality in Gaucher disease. Presented at: UNSPECIFIED.

Hughes, DA; Li, A; Holmes, AM; Reed, MC; Baker, RJ; Milligan, A; Richfield, L; ... Mehta, AB; + view all (2006) Anaemia in Anderson-Fabry disease: the role of hepcidin. Presented at: UNSPECIFIED.

Hughes, DA; Reed, M; Baker, RJ; Richfield, L; Milligan, A; Evans, S; Blincoe, M; ... Mehta, A; + view all (2006) Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease. J INHERIT METAB DIS , 29 21 - 21.

Hughes, R; Glynne-Jones, R; Grainger, J; Richman, P; Makris, A; Harrison, M; Ashford, R; ... Novell, JR; + view all (2006) Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? International Journal of Colorectal Disease , 21 (1) pp. 11-17.

I

Islam, L; Amary, MF; Idowu, B; Diss, T; Flanagan, AM; (2006) Frequent detection of beta-catenin gene mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion. In: (Proceedings) 190th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. (pp. p. 26). JOHN WILEY & SONS LTD

J

Jagsi, R; Makris, A; Goldberg, S; Taghian, A; (2006) Intra-European differences in the radiotherapeutic management of breast cancer: A survey study. CLINICAL ONCOLOGY , 18 (5) pp. 369-375.

Jellinek, DA; Levy, D; Maltby, E; Atkey, N; Hibberd, S; Crimmins, D; Stoeber, K; ... Wharton, SB; + view all (2006) Cytogenetic subtypes of oligodendroglioma differ in their apoptotic index, while the population of replication-licensed, non-proliferating cells is higher in anaplastic tumors but does not differ according to 1p,19q status. In: NEURO-ONCOLOGY. (pp. 459 - 459). DUKE UNIV PRESS

Jones, SF; Plummer, ER; Burris, HA; Razak, AR; Meluch, AA; Bowen, CJ; Williams, DH; ... Calvert, AH; + view all (2006) Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors. J Clin Oncol , 24 (18_suppl) 2027-.

Julia, LS; (2006) You Don't Have to Smoke to Get Lung Cancer. Sunday Telegraph, Stella Magazine

K

Kalve, I; Devitt, D; Little, AM; Liu, X; Tilanus, M; Marsh, SGE; Madrigal, JA; (2006) Evaluation of RSCA® as a novel, emerging HLA typing method. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 295-303). IHWG Press: Seattle.

Karavolos, S; Caplin, M; Benjamin, E; Crow, J; Mould, T; (2006) Primary mucinous carcinoid tumour of the ovary: a case report. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , 27 (6) pp. 618-620.

Kaufmann, M; Hortobagyi, GN; Goldhirsch, A; Scholl, S; Makris, A; Valagussa, P; Blohmer, JU; ... von Minckwitz, G; + view all (2006) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update. JOURNAL OF CLINICAL ONCOLOGY , 24 (12) pp. 1940-1949.

Khoja, L; Mulyati, M; Lee, SM; (2006) Secondline chemotherapy in NSCLC. Lung Cancer in Practice , 3 (1) pp. 6-7.

Kim, BS; Miyagawa, F; Bennett, CL; Clausen, BE; Katz, SI; (2006) Elimination of epidermal Langerhans cells or impairment of dermal dendritic cells does not abrogate the induction of localized graft-versus-host-disease-like skin disease. In: (Proceedings) 67th Annual Meeting of the Society-for-Investigative-Dermatology. (pp. p. 119). NATURE PUBLISHING GROUP

Kimata, Y; Yamano, H; (2006) Structural analysis sheds light on APC/C-mediated ubiquitylation. Dev. Cell , 10 (1) pp. 4-5.

Kleinert, J; Dehout, F; Schwarting, A; de, LAG; Ricci, R; Kampmann, C; Beck, M; ... Sunder-Plassmann, G; + view all (2006) Prevalence of uncontrolled hypertension in patients with Fabry disease. American Journal of Hypertension , 19 (8) pp. 782-787.

Klupsch, K; Downward, J; (2006) The protease inhibitor Ucf-101 induces cellular responses independently of its known target, HtrA2/Omi. CELL DEATH DIFFER , 13 (12) 2157 - 2159. 10.1038/sj.cdd.4401955.

Kocjan, G; (2006) What is the role of fine needle aspiration cytology in the multidisciplinary approach to breast carcinoma. In: Drinkovic, I, (ed.) Proceedings of the XIV World Congress on Breast Diseases. (pp. 105 - 108). MEDIMOND S R L

Kocjan, G; (2006) Fine Needle aspiration Cytology; Diagnostic Principles and Dilemmas. [Book]. (Vol.1). (1 vols). (1 ed.). Springer -Verlag Berlin Heidelberg: Germany.

Kogelberg, H; Sharma, SK; Qureshi, U; Tolner, B; Lowdell, M; Shabakhti, H; Robson, M; ... Chester, KA; + view all (2006) Clearance mechanism of a mannoseylated antibody enzyme fusion protein used in experimental cancer therapy. In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 65-).

Kogelberg, H; Sharma, SK; Qureshi, U; Tolner, B; Lowdell, M; Shahbakhti, H; Robson, M; ... Chester, KA; + view all (2006) Clearance Mechanism Of A Mannosylated Antibody-Enzyme Fusion Protein Used In Experimental Cancer Therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

Koukourakis, M.I.; Bentzen, S.M.; Giatromanolaki, A.; Wilson, G.D.; Daley, F.M.; Saunders, M.I.; Dische, S.; ... Harris, A.L.; + view all (2006) Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Journal of Clinical Oncology , 24 (5) pp. 727-735. 10.1200/jco.2005.02.7474.

Kyriakou, C; Rabin, N; Nathwani, A; Pizzey, A; Linch, DC; Yong, K; (2006) Factors influencing short term in vivo biodistribution of human bone marrow derived mesenchymal stem cells (hMSCs) in a xenogeneic animal model. In: BLOOD. (pp. 908A - 908A). AMER SOC HEMATOLOGY

L

Ladenstein, R; Whelan, J; Oberlin, O; Weston, C; Jurgens, H; (2006) Multivariate analysis based risk grouping of Ewing tumours with extrapulmonary metastatic disease. Results from the EURO EWING 99 Study. In:

Lai, CSL; Boshoff, C; Falzon, M; Lee, SM; (2006) Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. UNSPECIFIED

Lam, L; Berisha, F; Diss, TC; Flanagan, AM; (2006) Formalin-fixed paraffin-embedded material is a reliable source of RNA for molecular genetic analysis provided small fragments are targeted. In: (Proceedings) 190th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. (pp. p. 6). WILEY-BLACKWELL

Last, K; Maharaj, L; Perry, J; Strauss, S; Fitzgibbon, J; Lister, TA; Joel, S; (2006) The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Ann Oncol , 17 (5) 773-9-773-9.

Laun, K; Coggill, P; Palmer, S; Sims, S; Ning, ZM; Ragoussis, J; Volpi, E; ... Volz, A; + view all (2006) The leukocyte receptor complex in chicken is characterized by massive expansion and diversification of immunoglobulin-like loci. PLoS Genetics , 2 (5) , Article e73. 10.1371/journal.pgen.0020073. Green open access
file

Laurent, C; Quaglia, A; Foroni, L; Bioulac-Sage, P; Balabaud, C; Dhillon, AP; (2006) Genomic alteration is not associated with fatty and clear cell change in hepatocellular carcinomas and its precursor nodular lesions in cirrhotic liver. HEPATOL RES , 36 (1) 40 - 47. 10.1016/j.hepres.2006.06.003.

Le, NM; Sielaff, AM; Cooper, AJ; Mackay, H; Brown, T; Kotecha, M; O'Hare, C; ... Hartley, JA; + view all (2006) Binding of f-PIP, a pyrrole- and imidazole-containing triamide to the inverted CCAAT box-2 of the topoisomerase II alpha promoter and modulation of gene expression in cells. Bioorganic and Medicinal Chemistry Letters , 16 (24) pp. 1661-1664.

Ledermann, JA; Raja, F; (2006) Management strategies for partially platinum-sensitive ovarian cancer. American Journal of Cancer , 5 (5) pp. 341-354. 10.2165/00024669-200605050-00005.

Lee, YK; Shanafelt, T; Chan, D; Giaccia, A; Mukhopadhyay, D; Taccioli, C; Calin, G; ... Kay, NE; + view all (2006) Elevated HIF-1 alpha levels in CLLB cells may explain their autocrine VEGF secretion. In: BLOOD. (pp. 176A - 176A). AMER SOC HEMATOLOGY

Lehmann, DJ; Barnardo, MCNM; Fuggle, S; Quiroga, I; Sutherland, A; Warden, DR; Barnetson, L; ... Smith, AD; + view all (2006) Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity? J NEUROINFLAMM , 3 , Article 33. 10.1186/1742-2094-3-33. Green open access
file

Linhart, A; Hughes, DA; (2006) Age adjusted severity scoring for Fabry disease. Presented at: UNSPECIFIED.

Liobikas, J; Polianskyte, Z; Speer, O; Thompson, J; Alakoskela, J-M; Peitsaro, N; Franck, M; ... Eriksson, O; + view all (2006) Expression and purification of the mitochondrial serine protease LACTB as an N-terminal GST fusion protein in Escherichia coli. Protein Expression and Purification , 45 (2) pp. 335-342. 10.1016/j.pep.2005.08.006.

Liso, A; Capello, D; Marafioti, T; Tiacci, E; Cerri, M; Distler, V; Paulli, M; ... Falini, B; + view all (2006) Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. BLOOD , 108 (3) pp. 1013-1020. 10.1182/blood-2005-10-3949.

Louise, J; (2006) Thalidomide makes a comeback-but at what cost? Morning Star

M

MacGregor, EA; Frith, A; Ellis, J; Aspinall, L; Hackshaw, A; (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology , 67 (12) pp. 2154-2158.

MacGregor, EA; Frith, A; Ellis, J; Aspinall, L; Hackshaw, A; (2006) Prevention of menstrual attacks of migraine - A double-blind placebo-controlled crossover study. Neurology , 67 (12) pp. 2159-2163.

Maharaj, L; Popat, R; Chahwan, A; Lister, AT; Cavenagh, JD; Middleton, B; Rioja, A; ... Joel, SP; + view all (2006) The novel HDAC inhibitor UCL67022 is highly potent in multiple myeloma and non-Hodgkin's lymphoma and is enhanced by bortezomib. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 735A-735A). AMER SOC HEMATOLOGY

Mansour, MR; (2006) A role for aberrant Notch signaling in acute myeloid leukemia? LEUKEMIA & LYMPHOMA , 47 (11) pp. 2280-2281. 10.1080/10428190600908109.

Mantovani, J; Holic, N; Martinez, K; Danos, O; Perea, J; (2006) A high throughput method for genome-wide analysis of retroviral integration. Nucleic Acids Res , 34 (19) , Article e134. 10.1093/nar/gkl716.

Marafioti, T; Mason, DY; (2006) Diagnostic Immunohistopathology. Monoclonal Antibodies as Therapeutic Agents. [Digital scholarly resource]. http://www.hstalks.com/mono/index.htm

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davics, N; Tibbals, J; ... Burroughs, A; + view all (2006) Transarterial therapy for hepatocellular carcinoma (HCC) in cirrhosis: Is embolization as effective as chemoembolization? Systematic review of cohort and randomized studies. In: (Proceedings) 41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver. (pp. S106-S106). ELSEVIER SCIENCE BV

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, January 2006 update. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (3) pp. 225-226. 10.1111/j.1744-313X.2006.00589.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, October 2005 update*. Int J Immunogenet , 33 (1) pp. 63-64. 10.1111/j.1744-313X.2006.00566.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update April 2006. TISSUE ANTIGENS , 68 (3) pp. 270-272. 10.1111/j.1399-0039.2006.00655.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update August 2006. TISSUE ANTIGENS , 68 (6) pp. 537-539. 10.1111/j.1399-0039.2006.00711.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update December 2005. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (2) pp. 147-149. 10.1111/j.1744-313X.2006.00576.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update July 2006. HUMAN IMMUNOLOGY , 67 (12) pp. 1017-1018. 10.1016/j.humimm.2006.10.001.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update July 2006. TISSUE ANTIGENS , 68 (6) pp. 535-536. 10.1111/j.1399-0039.2006.00709.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update June 2006. TISSUE ANTIGENS , 68 (3) pp. 276-277. 10.1111/j.1399-0039.2006.00659.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update May 2006. TISSUE ANTIGENS , 68 (3) pp. 273-275. 10.1111/j.1399-0039.2006.00660.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update November 2005. TISSUE ANTIGENS , 67 (3) pp. 260-261. 10.1111/j.1399-0039.2006.00561.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update November 2005. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (2) pp. 145-146. 10.1111/j.1744-313X.2006.00575.x.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Wain, H; + view all (2006) Killer-cell Immunoglobulin-like Receptor (KIR) Nomenclature Report, 2002. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1196-1202). IHWG Press: Seattle.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2006) Nomenclature for factors of the HLA system, update September 2006. Tissue Antigens , 68 (6) pp. 540-542. 10.1111/j.1399-0039.2006.00713.x.

Mayer, A; Francis, RJ; Sharma, SK; Tolner, B; Springer, CJ; Martin, J; Boxer, GM; ... Begent, RH; + view all (2006) A Phase I Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug. Clinical Cancer Research , 12 (21) pp. 6509-6516.

Mayor, NP; Shaw, BE; Derralynn, AH; Maldonado-Torres, H; Madrigal, JA; Keshav, S; Marsh, SGE; (2006) Single nucleotide polymorphisms of the NOD2/CARD15 gene are associated with significant increases in disease relapse and mortality in recipients of an unrelated donor haematopoietic stem cell transplant for acute leukaemia. In: BLOOD. (pp. 151A - 151A). AMER SOC HEMATOLOGY

McCarville, MB; Streck, CJ; Dickson, PV; Li, CS; Nathwani, AC; Davidoff, AM; (2006) Angiogenesis inhibitors in a murine neuroblastoma model: Quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. Radiology , 240 (1) pp. 73-81. 10.1148/radiol.2401050709.

McDonald, S; Greaves, LG; Leedham, SJ; Preston, SL; Taylor, RW; Oukrif, D; Deheragoda, M; ... Wright, NA; + view all (2006) Monoclonal conversion in human gastric glands: Insights into stem cell and clonal architecture. In: JOURNAL OF PATHOLOGY. (pp. 29A - 29A). JOHN WILEY & SONS LTD

McDonald, SAC; Greaves, LG; Leedham, SJ; Yin-Lee, C; Deheragoda, M; Oukrif, D; Novelli, MR; ... Wright, NA; + view all (2006) Monoclonal conversion of human gastric glands provides insights into stem cell and clonal architecture. In: GUT. (pp. A28 - A28). B M J PUBLISHING GROUP

McTiernan, A; Whelan, J; Leahy, M; Woll, PJ; Judson, I; (2006) A phase II nonrandomised open-label study of liposomal daunorubicin (DaunoXome) in advanced soft tissue sarcoma. Sarcoma , 2006 10.1155/SARCOMA/41080. Gold open access

Mcintosh, J; Cochrane, M; Tuddenham, EGD; Davidoff, AM; Nathwani, AC; (2006) Expression of human FIX at therapeutic levels in nonhuman primates following a single peripheral vein infusion of low doses of self complementary AAV vector renews hope for haemophilia B gene therapy. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 18 - 18). BLACKWELL PUBLISHING

Meaburn, E; Butcher, LM; Schalkwyk, LC; Plomin, R; (2006) Genotyping pooled DNA using 100K SNP microarrays: a step towards genomewide association scans. Nucleic Acids Res. , 34 (4) , Article e27. 10.1093/nar/gnj027.

Mehta, A; (2006) Clinical experience with substrate reduction therapy. European Journal of Internal Medicine , 17 S13-15.

Mehta, A; (2006) Epidemiology and natural history of Gaucher's disease. European Journal of Internal Medicine (17) S2-S5.

Mickelson, E; Hurley, C; Ng, J; Tilanus, M; Carrington, M; Marsh, SGE; Rozemuller, E; ... Hansen, J; + view all (2006) 13th IHWS Shared Resources Joint Report. IHWG Cell and Gene Bank and reference cell panels. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 523-553). IHWG Press: Seattle.

Middleton, M.R.; Ranson, M.; Lee, S.M.; Bridgewater, J.A.; (2006) Phase I study of 4-bromothenylguanine (4-BTG, PaTrin 2), an alkyltransferase inactivator and temozolomide. Clinical Cancer Research , 6 (Suppl.) 538a.

Miretti, MM; Beck, S; (2006) Immunogenomics: molecular hide and seek. Hum Genomics , 2 (4) pp. 244-251.

Mita, MM; Ochoa, L; Rowinsky, EK; Kuhn, J; Schwartz, G; Hammond, LA; Patnaik, A; ... Cunningham, D; + view all (2006) A Phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (GenasenseTM, G3139) and irinotecan in patients with metastatic colorectal cancer. Advances in Gastrointestinal Cancers , 4 (1) pp. 20-21.

Morsi, H; Yong, KL; Jewell, AP; (2006) Preferential survival of acute lymphoblastic leukemia cells at 33 degrees C is associated with up-regulation of bcl-2. LEUKEMIA LYMPHOMA , 47 (6) 1117 - 1122. 10.1080/10428190500404498.

Mudie, N.Y.; Swerdlow, A.J.; Higgins, C.D.; Smith, P.; Qiao, Z.; Hancock, B.W.; Hoskin, P.J.; (2006) Risk of second malignancy after non-Hodgkin's lymphoma: a British cohort study. Journal of Clinical Oncology , 24 (10) pp. 1568-1574. 10.1200/JCO.2005.04.2200.

N

Nacheva, EP; Brazma, D; Grace, C; (2006) Screening CML for genetic imbalances by array CGH. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 5 - 5). BLACKWELL PUBLISHING

Nair, SB; Pipinikas, C; Kirby, R; Carter, N; Fenske, C; (2006) Molecular diagnosis and staging of prostate cancer using clusterin in real time reverse transcription polymerase chain reaction (RT-PCR). In: (Proceedings) Annual Meeting of the American-Urological-Association. (pp. pp. 485-486). LIPPINCOTT WILLIAMS & WILKINS

Ng, QS; Goh, V; Fichte, H; Klotz, E; Fernie, P; Saunders, MI; Hoskin, PJ; (2006) Lung cancer perfusion at multi-detector row CT: Reproducibility of whole tumor quantitative measurements. RADIOLOGY , 239 (2) pp. 547-553.

Nikitenko, L; Boshoff, C; (2006) Endothelial cells and cancer. Handb Exp Pharmacol (176 Pt 2) pp. 307-334.

Nikitenko, LL; Blucher, N; Fox, SB; Bicknell, R; (2006) Adrenomedullin and CGRP interact with endogenous calcitonin receptor-like receptor in human microvascular endothelial cells and induce its desensitisation via two different mechanisms. In: JOURNAL OF VASCULAR RESEARCH. (pp. 58 - 58). KARGER

Nikitenko, LL; Blucher, N; Fox, SB; Bicknell, R; Smith, DM; Rees, MC; (2006) Adrenomedullin and CGRP interact with endogenous calcitonin receptor-like receptor in endothelial cells and induce its desensitisation via two different mechanisms. In: JOURNAL OF HYPERTENSION. (pp. 62 - 62). LIPPINCOTT WILLIAMS & WILKINS

Nikitenko, LL; Cross, T; Campo, L; Turley, H; Leek, R; Manek, S; Bicknell, R; (2006) Expression of terminally glycosylated calcitonin receptor-like receptor in uterine leiomyoma: Endothelial phenotype and association with microvascular density. CLIN CANCER RES , 12 (19) 5648 - 5658. 10.1158/1078-0432.CCR-06-0852.

O

O'Donnell, P; Diss, TC; Whelan, J; Flanagan, AM; (2006) Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: Differentiation by molecular genetic studies. Skeletal Radiology , 35 (4) pp. 233-239. 10.1007/s00256-005-0006-z.

O'Donnell, P; Diss, TC; Whelan, J; Flanagan, AM; (2006) Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studies. Skeletal Radiology , 35 (4) pp. 345-350.

P

Pankhurst, T; Howie, AJ; Adu, D; Wallace, DMA; Lipkin, GW; (2006) Incidental neoplasms in renal biopsies. Nephrol Dial Transplant , 21 (1) pp. 64-69. 10.1093/ndt/gfi149.

Panner, A; Nakamura, JL; Parsa, AT; Rodriguez-Viciana, P; Berger, MS; Stokoe, D; Pieper, RO; (2006) mTOR-independent control of the extrinsic cell death pathway by Ra1A. In: NEURO-ONCOLOGY. (pp. 400 - 400). DUKE UNIV PRESS

Paston, S.J.; (2006) CMV epitope selection and its use in T cell reconstitution in patients undergoing haematopoietic stem cell transplantation. Doctoral thesis , University of London. Green open access
file

Patel, BR; Goldstone, AH; Ross, P; Foroni, L; Richards, S; Chopra, R; Fielding, AK; (2006) Clinical effect of Imatinib following remission induction in adult Philadelphia chromosome-positive acute lymphoblastic leukaemia: early results from the MRC UKALL12 Study. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 56 - 56). BLACKWELL PUBLISHING

Perisoglou, M; Seddon, B; Daniels, S; Mayne, N; Whelan, J; (2006) Incidence of delays in methotrexate toxicity in treatment of osteosarcoma. In:

Pescott, MA; Longair, I; Gardiner, C; Austin, SK; Machin, SJ; (2006) Acceptibility of patient self-testing of oral anticoagulation in new patients. In: (pp. p. 4122).

Pescott, MA; Longair, I; Gardiner, C; Austin, SK; Machin, SJ; (2006) Acceptibility of patient self-testing of oral anticoagulation in new patients. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 110B-110B). AMER SOC HEMATOLOGY

Pillay, OC; Wong, LF; Fong, TE; Crow, JC; Benjamin, E; Mould, T; Atiomo, W; ... Hardiman, P; + view all (2006) A study of the relationship between polycystic ovary syndrome and endometrial cancer. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY , 113 (7) p. 856.

Plummer, R; Lorigan, P; Evans, J; Steven, N; Middleton, M; Wilson, R; Snow, K; ... Calvert, H; + view all (2006) First and final report of a phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AG014699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM). J Clin Oncol , 24 (18_suppl) 8013-.

Plummer, R; Lorigan, P; Evans, J; Steven, N; Middleton, M; Wilson, R; Snow, K; ... Calvert, H; + view all (2006) First and final report of a phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AGO14699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 456S - 456S). AMER SOC CLINICAL ONCOLOGY

Plummer, R; Vidal, L; Li, L; Shaw, H; Perrett, R; Shahidi, M; Amelsberg, A; ... de Bono, J; + view all (2006) Phase I study of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, showing activity in tumours with mutated EGFR. EJC SUPPL , 4 (12) 173 - 174.

Pollard, S; Conti, L; Smith, A; (2006) Exploitation of adherent neural stem cells in basic and applied neurobiology. Regen Med , 1 (1) pp. 111-118. 10.2217/17460751.1.1.111.

Pollard, SM; Benchoua, A; Lowell, S; (2006) Neural stem cells, neurons, and glia. Methods Enzymol , 418 pp. 151-169. 10.1016/S0076-6879(06)18010-6.

Popat, R; Joel, S; Oakervee, H; Cavenagh, J; (2006) Bortezomib for multiple myeloma. Expert Opin Pharmacother , 7 (10) pp. 1337-1346. 10.1517/14656566.7.10.1337.

Popat, R; Oakervee, H; Curry, N; Foot, N; Morris, C; Drake, M; Agrawal, S; ... Cavenagh, JD; + view all (2006) Low dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for untreated multiple myeloma. In: (Proceedings) 46th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 99). WILEY-BLACKWELL PUBLISHING, INC

Popat, R; Oakervee, HE; Foot, N; Agrawal, S; Odeh, L; Craddock, C; Williams, C; ... Cavenagh, JD; + view all (2006) Low dose intravenous melphalan and bortezomib for relapsed multiple myeloma. In: (Proceedings) 46th Annual Scientific Meetign of the British-Society-for-Haematology. (pp. p. 98). BLACKWELL PUBLISHING

Popat, R; Williams, C; Cook, M; Craddock, C; Basu, S; Singer, C; Odeh, L; ... Cavenagh, JD; + view all (2006) A phase I/II trial of bortezomib, low dose intravenous melphalan and dexamethasone for patients with relapsed multiple myeloma. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 1011A-1011A). AMER SOC HEMATOLOGY

Posthouwer, D; Makris, M; Yee, TT; Fischer, K; Van Veen, J; Griffioen, A; Mauser-Bunschoten, EP; (2006) The natural history of hepatitis C in patients with bleeding disorders. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 20 - 20). BLACKWELL PUBLISHING

Posthouwer, D; Yee, TT; Makris, M; Fischer, K; Griffioen, A; Van Veen, J; Mauser-Bunschoten, EP; (2006) Response to antiviral therapy in patients with congenital bleeding disorders infected with hepatitis C. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 85 - 86). BLACKWELL PUBLISHING

Prieto-Hinojosa, A; Alejandro Madrigal, J; Shaw, BE; Mayor, NP; Marsh, SGE; Travers, PJ; Duarte, RF; (2006) High proportions of CD4+CD25(hi) T cells pretransplant correlate with worse overall survival after stem cell transplant. In: BLOOD. (pp. 891A - 892A). AMER SOC HEMATOLOGY

Pritzker, KPH; Gay, S; Jimenez, SA; Ostergaard, K; Pelletier, J-P; Revell, PA; Salter, D; (2006) Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis and Cartilage , 14 (1) pp. 13-29.

R

Rabin, N; Kyriakou, C; Benjamin, R; Pizzey, A; Gallagher, O; Singh, N; Buckle, C; ... Yong, K; + view all (2006) Gene modified human mesenchymal stem cells expressing osteoprotegerin inhibit osteoclast activation and increase trabecular bone area in a xenogeneic murine model of myeloma. In: BLOOD. (pp. 153A - 153A). AMER SOC HEMATOLOGY

Rabin, N; Kyriakou, C; Pizzey, A; Buckle, C; Prideaux, M; Croucher, P; Nathwani, A; (2006) Gene Modified Human Mesenchymal Stem Cells Expressing Osteoprotegerin Reverse Osteoclast Activation in a Xenogeneic Murine Model of Multiple Myeloma. MOLECULAR THERAPY , 13 S256-S256. 10.1016/j.ymthe.2006.08.740.

Rades, D; Stalpers, LJA; Schulte, R; Veninga, T; Basic, H; Engenhart-Cabilic, R; Schild, SE; (2006) Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients. EUROPEAN JOURNAL OF CANCER , 42 (8) pp. 1052-1056.

Rades, D; Stalpers, LJA; Veninga, T; Hoskin, PJ; (2006) Spinal reirradiation after short-course RT for metastatic spinal cord compression. International Journal of Radiation Oncology Biology Physics , 63 (3) pp. 872-875.

Rades, D; Stalpers, LJA; Veninga, T; Rudat, V; Schulte, R; Hoskin, PJ; (2006) Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer. The Journal of Urology , 175 (2) pp. 552-556.

Rades, D; Walz, J; Stalpers, LJA; Veninga, T; Schulte, R; Obralic, N; Wildfang, I; ... Schild, SE; + view all (2006) Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: Results of a retrospective multi-center study. EUROPEAN UROLOGY , 49 (5) pp. 846-852.

Ramaswami, U; Whybra, C; Parini, R; Pintos-Morell, G; Mehta, A; Sunder-Plassmann, G; Widmer, U; (2006) Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatrica , 95 (1) pp. 86-92.

Ranson, R; Middleton, MR; Bridgewater, J; Lee, SM; Dawson, M; Jowle, D; Halbert, G; ... Margison, GP; + view all (2006) Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA alkyltransferas: Phase 1 safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumours. Clinical Cancer Research , 12 (5) pp. 1577-1584.

Ravn, P; Patel, A; Andre, M; Bicknell, R; Begent, R; Pedley, B; Chester, K; (2006) Generation of Antibodies to Magic Roundabout 4, Robo4 using Phage Display. In: (Proceedings) NCRI Cancer Conference Proceedings.

Renard, C; Hart, E; Sehra, H; Beasley, H; Coggill, P; Howe, K; HarroW, J; ... Beck, S; + view all (2006) The genomic sequence and analysis of the swine major histocompatibility complex. GENOMICS , 88 (1) 96 - +. 10.1016/j.ygeno.2006.01.004.

Richfield, L; Bruce, R; Baker, R; Goodwin, S; Holmes, A; Hughes, D; Milligan, A; (2006) Phenotypical expression of mutation R227X exon 5 of the GLA gene (nucleotide change p.Arg227X c.608C > T) identified in a large UK kindred spanning eight generations in a well-documented family pedigree. ACTA PAEDIATR , 95 127 - 128.

Robinson, J; Waller, MJ; Fail, SC; Marsh, SGE; (2006) The IMGT/HLA and IPD databases. HUMAN MUTATION , 27 (12) pp. 1192-1199. 10.1002/humu.20406.

Robinson, J; Waller, MJ; Parham, P; Marsh, SGE; (2006) IMGT/HLA and IMGT/MHC – sequence databases for the study of the major histocompatibility complex. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 442-447). IHWG Press: Seattle.

Rodriguez-Viciana, P; McCormick, F; (2006) Characterization of interactions between Ras family GTPases and their effectors. METHOD ENZYMOL , 407 187 - 194. 10.1016/S0076-6879(05)07016-3.

S

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Lee, YC; Zhu, DL; Begent, RHJ; (2006) Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , 39 (1-3) 141 - 150. 10.1016/j.ijbiomac.2006.03.022.

Saunders, MI; Rojas, A; (2006) Burning issues in CERT. In: (Proceedings) 3rd International Conference on Translational Research and Pre-Clinical Strategies in Radiation Oncology. (pp. S19-S19). ELSEVIER IRELAND LTD

Scaffidi, P; (2006) Good news in the nuclear envelope: loss of lamin A might be a gain. Journal of Clinical Investigation , 116 (3) pp. 632-634. 10.1172/JCI27820.

Scaffidi, P; (2006) Lamin A-Dependent Nuclear Defects in Human Aging. Science , 312 (5776) pp. 1059-1063. 10.1126/science.1127168.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Kollman, C; Norren, HJ; (2006) The HLA Dictionary: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens In Immunobiology of the Human MHC. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1117-1119). IHWG Press: Seattle.

Schumacher, A; Kapranov, P; Flanagan, J; Kaminsky, Z; Yao, P; Vitkute, J; Winegarden, N; ... Petronis, A; + view all (2006) Microarray-based large scale profiling of DNA methylation. Nucleic Acids Research , 34 (2) pp. 528-542. Gold open access

Scully, M; Cavenagh, J; Benjamin, S; Mackie, I; Machin, S; Cohen, H; (2006) Disappearance of IgG antibody to ADAMTS 13 following rituximab in acute refractory thrombotic thrombocytopenic purpura. Presented at: 46th Annual Scientific Meeting of the British-Society-for-Haematology, Edinburgh, SCOTLAND.

Scully, M; Starke, R; Lee, R; Mackie, I; Machin, S; Cohen, H; (2006) Successful management of pregnancy in women with a history of TTP. Blood Coagulation and Fibrinolysis , 17 pp. 459-463.

Scully, M; Starke, R; Lee, R; Mackie, I; Machin, S; Cohen, H; (2006) Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. BLOOD COAGUL FIBRIN , 17 (6) 459 - 463.

Sekhon, R; Knock, J; Shah, M; Maude, K; Stoeber, K; Williams, G; Howdle, P; ... Watkins, R; + view all (2006) MCMs and geminin: Similar expression but different relationship to survival in small bowel compared to gastric cancer. In: JOURNAL OF PATHOLOGY. (pp. 11 - 11). JOHN WILEY & SONS LTD

Senzolo, M; Patch, D; Cholongitas, E; Triantos, C; Marelli, L; Stigliano, R; Dhillon, AP; (2006) Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt. Transplantation , 82 pp. 132-135.

Shah, A; Peat, J; Maldonado-Torres, H; Marsh, SGE; Little, A-M; (2006) HLA-DQA1 and DQB1 alleles in Caucasoid and Asian donors from bone marrow registry. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (4) p. 322.

Shah, JS; Hughes, D; Tayebjee, M; Macfadyen, R; Mehta, A; Elliott, PM; (2006) Extracellular matrix turnover and disease severity in Anderson-Fabry disease. In: ACTA PAEDIATR. (pp. 118 - 118). TAYLOR & FRANCIS AS

Shanley, S; McReynolds, K; Ardern, JA; Ahern, R; Fernando, I; Yarnold, J; Evans, G; ... Easton, DAER; + view all (2006) Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clinical Cancer Research , 1 (12) pp. 7025-7032.

Shaw, BE; Boswell, T; Byrne, JL; Yates, C; Russell, NH; (2006) An MRSA outbreak in a stem cell transplant unit: analysis before and after a highly effective eradication strategy. In: BONE MARROW TRANSPLANTATION. (pp. S163 - S164). NATURE PUBLISHING GROUP

Shaw, BE; Byrne, JL; Das-Gupta, E; Carter, I; Russell, NH; (2006) Converting mixed chimerism to full donor chimerism in recipients of campath-containing reduced-intensity transplants reduces the relapse risk and improves survival compared to those with persistent full donor chimerism. In: BONE MARROW TRANSPLANTATION. (pp. S101 - S102). NATURE PUBLISHING GROUP

Shaw, BE; Byrne, JL; Das-Gupta, E; Carter, I; Russell, NH; (2006) Low pre-DLI lymphocytes counts are predictive of good disease responses in patients with mixed chimerism following campath-containing reduced intensity transplants. In: BLOOD. (pp. 81A - 81A). AMER SOC HEMATOLOGY

Shaw, BE; Marsh, SGE; Madrigal, JA; (2006) Role of HLA matching in unrelated donor transplant – An update of the Anthony Nolan data. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1392-1394). IHWG Press: Seattle.

Shaw, BE; Marsh, SGE; Mayor, NP; Russell, NH; Madrigal, JA; (2006) HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood , 107 (3) pp. 1220-1226. 10.1182/blood-2005-08-3121. Green open access
file

Shaw, BE; Potter, MN; Prentice, HG; Mayor, N; Pay, AL; Marsh, SGE; Madrigal, JA; (2006) Graft versus host disease in matched T cell depleted unrelated donor haematopoietic stem cell transplants. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 635-638). IHWG Press: Seattle.

Shaw, BE; Potter, MN; Prentice, HG; Mayor, N; Pay, AL; Travers, P; Marsh, SGE; (2006) Disease relapse following volunteer donor haematopoietic stem cell transplantation. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 631-634). IHWG Press: Seattle.

Shaw, H; Plummer, R; Vidal, L; Perrett, R; Pilkington, M; Temple, G; Fong, P; ... De Bono, J; + view all (2006) A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in patients with advanced solid tumours. J Clin Oncol , 24 (18_suppl) 3027-.

Short, S; (2006) UNSPECIFIED In: (Proceedings) 3rd International Conference on Translational Research and Preclinical Strategies in Radiation Oncology.

Short, S; (2006) BBC 6 O'Clock news. UNSPECIFIED

Silva, E.; (2006) The role of tumour suppressor fat in the patterning and development of the Drosophila eye. Doctoral thesis , University of London. Green open access
file

Sizer, B; Makris, A; Barone, C; Mainwaring, P; Eggleton, P; (2006) QoL and resource use analysis of tegafur-uracil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study. In: (pp. 178S-178S).

Slack, E.M.C.; (2006) Regulation of dendritic cell function by Dectin-1. Doctoral thesis , University of London. Green open access
file

Soffietti, R; Cornu, P; Delattre, JY; Grant, R; Graus, F; Grisold, W; Heimans, J; ... Vecht, C; + view all (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. EUROPEAN JOURNAL OF NEUROLOGY , 13 (7) pp. 674-681.

Spiro, S.G.; James, L.E.; Rudd, R.M.; Trask, C.W.; Tobias, J.S.; Snee, M.; Gilligan, D.; ... Hackshaw, A.K.; + view all (2006) Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. Journal of Clinical Oncology , 24 (24) pp. 3823-3830. 10.1200/jco.2005.05.3181.

Spiro, SG; James, LE; Rudd, RM; Trask, CW; Tobias, JS; Snee, M; Gilligan, D; ... Hackshaw, AK; + view all (2006) Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis. Journal of Clinical Oncology , 24 (24) pp. 3823-3830. 10.1200/JCO.2005.05.3181.

Stainsby, D; Cohen, H; Jones, H; (2006) The 2005 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Stainsby, D; JONES, H; COHEN, H; (2006) A decade of haemovigilance: informing transfusion safety. In: (Proceedings) British society for haematology annual scientific meeting.

Stainsby, D; Jones, H; Asher, D; Atterbury, C; Boncinelli, A; Brant, L; Chapman, CE; ... Group, SS; + view all (2006) Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfusion medicine reviews , 20 pp. 273-282.

Starke, R; MacKie, I; Drummond, O; MacGregor, I; Harrison, P; MacHin, S; (2006) Prion protein in patients with renal failure. Transfusion Medicine , 16 (3) pp. 165-168. 10.1111/j.1365-3148.2006.00662.x.

Starke, R; Machin, S; Scully, M; Purdy, G; Mackie, I; (2006) ADAMTS13 antigen levels in 7 TTP patients studied longitudinally. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 48 - 48). BLACKWELL PUBLISHING

Starke, R; Mackie, I; Drummond, O; MacGregor, I; Harrison, P; Machin, S; (2006) Prion protein in patients with renal failure. TRANSFUSION MED , 16 (3) 165 - 168. 10.1111/j.1365-3148.2006.00662.x.

Stebbing, J; Mazhar, D; Palmieri, C; Thirlwell, C; Powles, T; Nelson, M; Gazzard, B; (2006) Non cutaneous AIDS-associated Kaposi's sarcoma. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 533S - 533S). AMER SOC CLINICAL ONCOLOGY

Stebbing, J; Mazhar, D; Palmieri, C; Thirlwell, C; Powles, T; Nelson, M; Gazzard, B; (2006) Non cutaneous AIDS-associated Kaposi's sarcoma. J Clin Oncol , 24 (18_suppl) 9555-.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; Wickremasinghe, RG; (2006) Generation of reactive oxygen species by parthenolide rapidly and selectively induces apoptosis of B-chronic lymphocytic leukaemia (CLL) cells via a p53 independent pathway. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 53 - 53). BLACKWELL PUBLISHING

Stephens, R; Hoskin, P; (2006) Clinical trials and modern advertising: The Lung Cancer Trials Flowchart. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Steptoe, A; Wright, CE; O'Donnell, K; Brydon, L; Wardle, J; (2006) Parental adiposity and cortisol awakening responses in young men and women. PSYCHONEUROENDOCRINOLOGY , 31 (9) pp. 1117-1126. 10.1016/j.psyneuen.2006.07.004.

Strauss, SJ; Maharaj, L; Hoare, S; Johnson, PW; Radford, JA; Vinnecombe, S; Millard, L; ... Lister, TA; + view all (2006) Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity. J Clin Oncol , 24 (13) pp. 2105-2112. 10.1200/JCO.2005.04.6789.

Strauss, SJ; Morschhauser, F; Rech, J; Repp, R; Solal-Celigny, P; Zinzani, PL; Engert, A; ... Lister, TA; + view all (2006) Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin’s lymphoma. J Clin Oncol , 24 (24) pp. 3880-3886. 10.1200/JCO.2006.05.6291.

Stubbs, B; Douek, M; Loizidou, M; Hall-Craggs, M; Usiskin, S; Falzon, M; (2006) Evaluating the role of breast cancer angiogenesis and lymphangiogenesis on dynamic contrast enhanced MRI. In: (pp. 33-).

Symeonidis, A; Hughes, D; Richfield, L; Mehta, A; (2006) Variation of serum lipid profile during enzyme replacement therapy, in patients with type 1 gauchers disease. In: BLOOD. (pp. 39B - 39B). AMER SOC HEMATOLOGY

Szlosarek, PW; Fennell, DA; Rudd, RM; Lind, M; Ranson, M; Hackshaw, A; Bomalaski, JS; (2006) A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma. In: (pp. S54-S54). ELSEVIER IRELAND LTD

T

Takahashi, M; Kikuchi, M; Ohkura, N; Yaguchi, H; Nagamura, Y; Ohnami, S; Ushiama, M; ... Tsukada, T; + view all (2006) Detection of APC gene deletion by double competitive polymerase chain reaction in patients with familial adenomatous polyposis. Int J Oncol , 29 (2) pp. 413-421.

Tedoldi, S; Paterson, JC; Cordell, J; Tan, S-Y; Jones, M; Manek, S; Dei Tos, AP; ... Marafioti, T; + view all (2006) Jaw I/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. JOURNAL OF PATHOLOGY , 209 (4) pp. 454-463. 10.1002/path.2002.

Tedoldi, S; Paterson, JC; Cordell, J; Tan, SY; Jones, M; Manek, S; Dei Tos, AP; ... Marafioti, T; + view all (2006) Jaw I/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. Journal of Pathology , 209 (4) pp. 454-463. 10.1002/path.2002.

Thompson, J; Lepikhova, T; Teixido-Travesa, N; Whitehead, MA; Palvimo, JJ; Jänne, OA; (2006) Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription. The EMBO Journal , 25 (12) pp. 2757-2767. 10.1038/sj.emboj.7601161.

Thomson, KJ; Mackinnon, S; Peggs, KS; (2006) T-cell depleted allogeneic haematopoietic stem cell transplantation and salvage donor lymphocyte infusions: a viable option in the era of reduced intensity transplantation? In: Davidson, DF, (ed.) Bone marrow transplantation. (pp. 57-82). Nova Biomedical

Tipping, AJ; Pina, C; Castor, A; Atzberger, A; Hong, D; Lazzari, L; May, G; ... Enver, T; + view all (2006) Enforced expression of GATA-2 confers quiescence on human hematopoietic stem and progenitor cells in in vitro and in vivo. In: BLOOD. (pp. 29A - 29A). AMER SOC HEMATOLOGY

Tolboom, TCA; Zhang, Y-H; Henriquez, NV; Nelissen, RGHH; Toes, REM; Noteborn, MHM; Huizinga, TWJ; (2006) Fibroblast-like synoviocytes from patients with rheumatoid arthritis are more sensitive to apoptosis induced by the viral protein, apoptin, than fibroblast-like synoviocytes from trauma patients. Clin Exp Rheumatol , 24 (2) pp. 142-147.

Tolner, B; Hillyer, T; Smith, L; Begent, RHJ; Contreras, R; Chester, KA; (2006) A Recombinant Antibody-Enzyme Fusion Protein Produced in Pichia Pastoris in Compliance with EU Clinical Trials Directive for Phase I/II Cancer Trials. In: (Proceedings) NCRI Cancer Conference Proceedings.

Tolner, B.; Smith, L.; Begent, R.H.J.; Chester, K.A.; (2006) Expanded-bed adsorption immobilized-metal affinity chromatography. Nature Protocols , 1 (3) pp. 1213-1222. 10.1038/nprot.2006.127.

Tolner, B.; Smith, L.; Begent, R.H.J.; Chester, K.A.; (2006) Production of recombinant protein in Pichia pastoris by fermentation. Nature Protocols , 1 (2) pp. 1006-1021. 10.1038/nprot.2006.126.

Toumpanakis, C; Meyer, T; Standish, R; Beisnab, E; Buscombe, J; Caplin, ME; (2006) Goblet cell carcinoid tumours (Adenocarcinoid). In: (Proceedings) 3rd Annual Conference of the European-Neuroendocrine-Tumor-Society (ENETS). (pp. p. 50). KARGER

U

Ungerechts, G; Springfeld, C; Fielding, A; Cattaneo, R; (2006) Next Generation Measles Virus Vectors for Oncolytic Therapy: Targeted, Armed and Stealth. MOLECULAR THERAPY , 13 S373-S373. 10.1016/j.ymthe.2006.08.1060.

V

Van Bueren, KL; Ivins, S; Roberts, C; James, C; Lindsay, E; Baldini, A; Scambler, P; (2006) Identification of potential Tbx1 targets in a mouse model of DiGeorge syndrome. In: GENETICAL RESEARCH. (pp. 73 - 73). CAMBRIDGE UNIV PRESS

Vaughan, B; Howard, J; Brazma, D; Nacheva, E; (2006) Loss of JAK2 in CML cell lines. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 287B-287B). AMER SOC HEMATOLOGY

Venables, K; Miles, EA; Aird, EGA; Hoskin, PJ; (2006) What is the optimum breast plan: a study based on the START trial plans. British Journal of Radiology , 79 (945) pp. 734-739.

Veron, P; Boutin, S; Bernard, J; Danos, O; Davoust, J; Masurier, C; (2006) Efficient transduction of monocyte- and CD34+-derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation. J Gene Med , 8 (8) pp. 951-961. 10.1002/jgm.923.

Vives, V; Su, J; Zhong, S; Ratnayaka, I; Slee, E; Goldin, R; Lu, X; (2006) ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth. Genes and Development , 20 pp. 1262-1267.

Vujovic, S; Henderson, SR; Flanagan, AM; Clements, MO; (2006) Notch signalling in self-renewal and differentiation of human mesenchymal stem cells.

Vujovic, S; Tiraboco, R; Henderson, S; Boschoff, C; Flanagan, AM; (2006) Microarray analysis of mesenchymal tumours identifies brachyury, a novel biomarker for chordomas. In: (Proceedings) 190th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. (pp. p. 1). WILEY-BLACKWELL

van Gestel, RA; Surinova, S; Rijken, P; O'Flaherty, M; Heck, AJR; Killian, JA; de Kroon, AI; (2006) Blue-native gel electrophoresis reveals role of cardiolipin in yeast mitochondrial supercomplex assembly and stability. In: (pp. S197-S197). AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC

W

Ward, KN; Leong, HN; Nacheva, EP; Howard, J; Atkinson, CE; Davies, NWS; Griffiths, P; (2006) High level HHV-6 DNA and viral chromosomal integration. In: JOURNAL OF CLINICAL VIROLOGY. (pp. S31 - S31). ELSEVIER SCIENCE BV

Whelan, J; Bielack, S; Marina, N; Smeland, S; Bernstein, M; (2006) . EURAMOS 1 - international randomised trial in a rare cancer: last of a soon-to-be extinct species or hope for the future? In:

Whelan, J; Dolbear, C; Davies, E; Moller, H; (2006) Where do teenagers and young adults receive treatment for cancer? In:

Whelan, J; McTiernan, A; Weston, C; Douglas, C; Grimer, R; Cassoni, A; Paulussen, M; ... Lewis, I; + view all (2006) Consequences of different approaches to local treatment of Ewing's sarcoma within an international randomised controlled trial: Analysis of EICESS-92. In: (pp. 528S-528S).

Whelan, JS; Cassoni, AM; Pollock, R; (2006) Bone. In: Price, P and Sikora, K, (eds.) Treatment of Cancer. : London.

Whelan, JS; McTiernan, A; Weston, C; Douglas, C; Grimer, R; Cassoni, A; Spooner, D; ... Lewis, I; + view all (2006) Consequences of different approaches to local treatment of Ewing’s sarcoma within an international randomised controlled trial: analysis of EICESS-92. In:

Whelan, JS; Seddon, BM; Perisoglou, M; (2006) Current Management of Osteosarcoma. Current Treatment Options in Oncology , 7 pp. 444-455.

Whitaker, DC; Stygall, J; Harrison, MJG; Mackie, IJ; Kemp, M; Hooper, J; Pugsley, WB; (2006) Leucocyte-depleting arterial line filtration does not reduce myocardial injury assessed by Troponin T during routine coronary artery bypass grafting using crossclamp fibrillation. Perfusion , 21 pp. 1-7.

Wilkins, DK; Mayer, A; (2006) Development of antibodies for cancer therapy. EXPERT OPIN BIOL TH , 6 (8) 787 - 796. 10.1517/14712598.6.8.787.

Wilkins, DK; Mayer, A; (2006) Development of antibodies for cancer therapy. Expert Opinion on Biological Therapy , 6 (8) pp. 787-796. 10.1517/14712598.6.8.7.87.

Wilson, GD; Saunders, MI; Dische, S; Daley, FM; Buffa, FM; Richman, PI; Bentzen, SM; (2006) Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapy. EUROPEAN JOURNAL OF CANCER , 42 (3) pp. 363-371.

Woodhams, JH; Macrobert, AJ; Novelli, MR; Brown, SG; (2006) Quantitative studies in normal colon and trnsplanted tumours. Cancer , 118 (2) pp. 477-482. 10.1002/ijc.21335.

Wortham, N.C.; (2006) Functional genetics of hereditary and sporadic uterine leiomyomas. Doctoral thesis , University of London. Green open access
file

Y

Yamaguchi, M; Fujimura, K; Toga, H; Khwaja, A; Okamura, N; Chopra, R; (2006) The SBDS gene regulates viability of myeloid precursor cells and is associated with high ROS production and telomere shortening in the SBDS downregulated cells. In: BLOOD. (pp. 468A - 468A). AMER SOC HEMATOLOGY

Z

Zhang, JC; Hughes, SE; (2006) Role of the ephrin and Eph receptor tyrosine kinase (RTK) familes in angiogenesis of the cardiovascular system. The Journal of Pathology (208) pp. 453-461.

Zhang, JC; HughesS, E; (2006) Role of the ephin and Eph receptor tyrosine kinase (RTK) families in angiogensis and development of the cardiovascular system. The Journal of Pathology (208) pp. 453-461.

This list was generated on Sun May 27 02:43:04 2018 BST.